Phathom Pharmaceuticals (PHAT) Notes Payables (2018 - 2019)
Phathom Pharmaceuticals (PHAT) posted quarterly Notes Payables of $95.2 million for Q3 2019, up 4783.54% quarter-over-quarter from $2.0 million in Q4 2018.
Phathom Pharmaceuticals (PHAT) Notes Payables (2018 - 2019) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Notes Payables for 2 consecutive years, with $95.2 million the latest figure, recorded in Q3 2019.
- In Q3 2019, Notes Payables changed N/A year-over-year to $95.2 million; the TTM figure through Sep 2019 stood at $95.2 million (changed N/A YoY), while the FY2018 annual figure was $2.0 million, changed N/A from the prior year.
- Notes Payables rose to $95.2 million in Q3 2019 per PHAT's latest filing, from $2.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $95.2 million in Q3 2019 and bottomed at $2.0 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 95.23 Mn |
| Dec 31, 2018 | 1.95 Mn |